Literature DB >> 14218621

CLINICAL PHARMACOLOGICAL STUDIES WITH DEBRISOQUIN SULFATE, A NEW ANTIHYPERTENSIVE AGENT.

W B ABRAMS, R POCELINKO, M KLAUSNER, L HANAUER, E N WHITMAN.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS; CLINICAL RESEARCH; DRUG THERAPY; DYE DILUTION TECHNIC; HEART; HEART RATE; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; NOREPINEPHRINE; PHARMACOLOGY; TYRAMINE

Mesh：

Substances：

Year:  1964        PMID： 14218621     DOI： 10.1002/j.1552-4604.1964.tb00372.x

Source DB:  PubMed          Journal:  J New Drugs        ISSN： 0096-0284


× No keyword cloud information.
  4 in total

Review 1.  Cytochrome P450 2U1, a very peculiar member of the human P450s family.

Authors:  L Dhers; L Ducassou; J-L Boucher; D Mansuy
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

2.  Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure.

Authors:  D Athanassiadis; W I Cranston; B E Juel-Jensen; D O Oliver
Journal:  Br Med J       Date:  1966-09-24

3.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

4.  The human pupil as a model for clinical pharmacological investigations.

Authors:  P Turner
Journal:  J R Coll Physicians Lond       Date:  1975-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.